Since CNBC highlighted the stock's attractive valuation in August, shares have gained around 20%. Why we expect more upside ahead. West Pharmaceutical raises its full-year earnings outlook as strong Q3 results, premium products, and operating leverage drive profit growth. There are valuation concerns with West Pharmaceutical's $364.98 share price, implying excessive confidence in future profit growth. High-value component business drives margin expansion, but.